For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251113:nRSM4604Ha&default-theme=true
RNS Number : 4604H Cicor Technologies Ltd 13 November 2025
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Cicor Technologies Ltd.
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a
trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form Cicor Technologies Ltd.
relates:
Use a separate form for each offeror/offeree
(d) Is the discloser the offeror or the offeree? Offeror
(e) Date position held: 12 November 2025
The latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making No
disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security: Ordinary (CHF 10.00)
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: Nil - Nil -
(2) Cash-settled derivatives: Nil - Nil -
(3) Stock-settled derivatives (including options) and agreements to Nil - Nil -
purchase/sell:
Nil - Nil -
TOTAL:
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: N/A
Details, including nature of the rights concerned and relevant percentages: N/A
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO
THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including
directors' and other employee options) of any person acting in concert with
the party to the offer making the disclosure:
A) Interests in ordinary shares in Cicor Technologies Ltd. held by directors
and executive leadership team of Cicor Technologies Ltd. and their close
relatives and related trusts
Name Number of Cicor Technologies Ltd. ordinary shares Percentage of issued ordinary share capital of Cicor Technologies Ltd. (%) 1
(#_ftn1)
Daniel Frutig 2 (#_ftn2) 9,101 0.21
Norma Corio 3 (#_ftn3) 1,278 0.03
Denise Koopmans 4 (#_ftn4) 1,685 0.04
Alexander Hagemann 18,534 0.42
Peter Neumann 5,231 0.12
Marco Kechele 2,303 0.05
Total 38,132 0.87
B) Interests held as options or awards (whether vested or unvested and whether
or not subject to conditions) held by directors and executive leadership team
of Cicor Technologies Ltd. in ordinary shares in Cicor Technologies Ltd.
Name Scheme under which granted Date of grant Price at grant (exercise price) (CHF) Number of ordinary shares Vesting date Expiry date
Daniel Frutig N/A 5 (#_ftn5) 17 April 2025 Nil 1,093 16 April 2026 N/A
Norma Corio N/A 6 (#_ftn6) 17 April 2025 Nil 875 16 April 2026 N/A
Denise Koopmans N/A 7 (#_ftn7) 17 April 2025 Nil 875 16 April 2026 N/A
Alexander Hagemann PSOP 2022-2024 1 January 2022 52.80 4,032 31 December 2024 8 (#_ftn8) 31 December 2028
PSOP 2023-2025 1 January 2023 42.90 6,743 31 December 2025 9 (#_ftn9) 31 December 2029
PSOP 2024-2026 1 January 2024 49.80 22,430 31 December 2026 31 December 2030
PSOP 2025-2027 1 January 2025 60.00 23,726 31 December 2027 31 December 2031
PSP 2023-2025 1 January 2023 Nil 4,578 31 December 2025 10 (#_ftn10) N/A
PSP 2024-2026 1 January 2024 Nil 10,892 31 December 2026 N/A
PSP 2025-2027 1 January 2025 Nil 9,340 31 December 2027 N/A
Special PSP 1 September 2025 Nil 2,324 31 December 2027 N/A
Peter Neumann PSOP 2023-2025 1 January 2023 42.90 3,372 31 December 2025 11 (#_ftn11) 31 December 2029
PSOP 2024-2026 1 January 2024 49.80 11,691 31 December 2026 31 December 2030
PSOP 2025-2027 1 January 2025 60.00 12,513 31 December 2027 31 December 2031
PSP 2023-2025 1 January 2023 Nil 2,288 31 December 2025 N/A
PSP 2024-2026 1 January 2024 Nil 5,676 31 December 2026 N/A
PSP 2025-2027 1 January 2025 Nil 4,926 31 December 2027 N/A
Special PSP 1 September 2025 Nil 2,008 31 December 2027 N/A
Marco Kechele PSOP 2023-2025 1 January 2023 42.90 3,372 31 December 2025 12 (#_ftn12) 31 December 2029
PSOP 2024-2026 1 January 2024 49.80 10,059 31 December 2026 31 December 2030
PSOP 2025-2027 1 January 2025 60.00 10,826 31 December 2027 31 December 2031
PSP 2023-2025 1 January 2023 Nil 2,288 31 December 2025 N/A
PSP 2024-2026 1 January 2024 Nil 4,884 31 December 2026 N/A
PSP 2025-2027 1 January 2025 Nil 4,262 31 December 2027 N/A
Special PSP 1 September 2025 Nil 2,008 31 December 2027 N/A
C) Interests in ordinary shares in Cicor Technologies Ltd. held by OEP 80 B.V.
Name Number of Cicor Technologies Ltd. ordinary shares Percentage of issued ordinary share capital of Cicor Technologies Ltd. (%)
OEP 80 B.V. 1,881,026 42.86
B) Interests held as options or awards (whether vested or unvested and whether
or not subject to conditions) held by directors and executive leadership team
of Cicor Technologies Ltd. in ordinary shares in Cicor Technologies Ltd.
Name Scheme under which granted Date of grant Price at grant (exercise price) (CHF) Number of ordinary shares Vesting date Expiry date
Daniel Frutig N/A 5 (#_ftn5) 17 April 2025 Nil 1,093 16 April 2026 N/A
Norma Corio N/A 6 (#_ftn6) 17 April 2025 Nil 875 16 April 2026 N/A
Denise Koopmans N/A 7 (#_ftn7) 17 April 2025 Nil 875 16 April 2026 N/A
Alexander Hagemann PSOP 2022-2024 1 January 2022 52.80 4,032 31 December 2024 8 (#_ftn8) 31 December 2028
PSOP 2023-2025 1 January 2023 42.90 6,743 31 December 2025 9 (#_ftn9) 31 December 2029
PSOP 2024-2026 1 January 2024 49.80 22,430 31 December 2026 31 December 2030
PSOP 2025-2027 1 January 2025 60.00 23,726 31 December 2027 31 December 2031
PSP 2023-2025 1 January 2023 Nil 4,578 31 December 2025 10 (#_ftn10) N/A
PSP 2024-2026 1 January 2024 Nil 10,892 31 December 2026 N/A
PSP 2025-2027 1 January 2025 Nil 9,340 31 December 2027 N/A
Special PSP 1 September 2025 Nil 2,324 31 December 2027 N/A
Peter Neumann PSOP 2023-2025 1 January 2023 42.90 3,372 31 December 2025 11 (#_ftn11) 31 December 2029
PSOP 2024-2026 1 January 2024 49.80 11,691 31 December 2026 31 December 2030
PSOP 2025-2027 1 January 2025 60.00 12,513 31 December 2027 31 December 2031
PSP 2023-2025 1 January 2023 Nil 2,288 31 December 2025 N/A
PSP 2024-2026 1 January 2024 Nil 5,676 31 December 2026 N/A
PSP 2025-2027 1 January 2025 Nil 4,926 31 December 2027 N/A
Special PSP 1 September 2025 Nil 2,008 31 December 2027 N/A
Marco Kechele PSOP 2023-2025 1 January 2023 42.90 3,372 31 December 2025 12 (#_ftn12) 31 December 2029
PSOP 2024-2026 1 January 2024 49.80 10,059 31 December 2026 31 December 2030
PSOP 2025-2027 1 January 2025 60.00 10,826 31 December 2027 31 December 2031
PSP 2023-2025 1 January 2023 Nil 2,288 31 December 2025 N/A
PSP 2024-2026 1 January 2024 Nil 4,884 31 December 2026 N/A
PSP 2025-2027 1 January 2025 Nil 4,262 31 December 2027 N/A
Special PSP 1 September 2025 Nil 2,008 31 December 2027 N/A
C) Interests in ordinary shares in Cicor Technologies Ltd. held by OEP 80 B.V.
Name Number of Cicor Technologies Ltd. ordinary shares Percentage of issued ordinary share capital of Cicor Technologies Ltd. (%)
OEP 80 B.V. 1,881,026 42.86
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the party to
the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer making the disclosure, or any person acting in
concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
Name Agreement, arrangement or understanding Number of Cicor Technologies Ltd. ordinary shares held by relevant person(s) Percentage of issued ordinary share capital of Cicor Technologies Ltd.
that the agreement, arrangement or understanding relates to 13 (#_ftn13)
Daniel Frutig 14 (#_ftn14) Contractual agreement to not dispose of shares for a three-year period ending 1,220 0.03
18 April 2026
Contractual agreement to not dispose of shares for a three-year period ending 1,479 0.03
19 April 2027
Contractual agreement to not dispose of shares for a three-year period ending 1,962 0.04
18 April 2028
Norma Corio 15 (#_ftn15) Contractual agreement to not dispose of shares for a three-year period ending 493 0.01
19 April 2027
Contractual agreement to not dispose of shares for a three-year period ending 785 0.02
18 April 2028
Denise Koopmans 16 (#_ftn16) Contractual agreement to not dispose of shares for a three-year period ending 407 0.01
18 April 2026
Contractual agreement to not dispose of shares for a three-year period ending 493 0.01
19 April 2027
Contractual agreement to not dispose of shares for a three-year period ending 785 0.02
18 April 2028
Alexander Hagemann Contractual agreement to not dispose of shares for a three-year period ending 1,179 0.03
1 September 2028
Peter Neumann Contractual agreement to not dispose of shares for a three-year period ending 1,018 0.02
1 September 2028
Marco Kechele Contractual agreement to not dispose of shares for a three-year period ending 1,018 0.02
1 September 2028
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer making the disclosure, or any person acting in
concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) No
Supplemental Form 8 (SBL) No
Date of disclosure: 13 November 2025
Contact name: Lukas Nänni
Telephone number: +41 71 913 73 09
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
1 (#_ftnref1) Excludes treasury shares. Percentages have been given to two
decimal places.
2 (#_ftnref2) Shares are held through Daniel Frutig, his close relatives
(Eva Frutig, Anna Frutig) and an associated company (EvolutionF AG).
3 (#_ftnref3) Shares are jointly held by Norma Corio and her close relative
(Lawrence Corio).
4 (#_ftnref4) Shares are held through an associated company (K+Co Consulting
GmbH).
5 (#_ftnref5) These shares were awarded as part of the overall remuneration
package for the board of directors for the 2025-2026 financial year.
6 (#_ftnref6) As above.
7 (#_ftnref7) As above.
8 (#_ftnref8) The vesting date for these options based on applicable scheme
rules is as stated. However, in practice, board approval of satisfaction of
applicable conditions in respect of these options took place in 18 April 2025
and the stated number of options vested thereafter.
9 (#_ftnref9) For options granted under the PSOP, vesting of the relevant
options is subject to board approval based on the satisfaction of applicable
conditions, which may take place later than 31 December of the relevant year.
10 (#_ftnref10) For shares granted under the PSP, vesting of the relevant
shares is subject to board approval based on the satisfaction of applicable
conditions, which may take place later than 31 December of the relevant year.
11 (#_ftnref11) As above.
12 (#_ftnref12) As above.
13 (#_ftnref13) Agreements, arrangements or understandings set out in this
table relate to shares held by the relevant person(s) as disclosed under
section 3(A) above.
14 (#_ftnref14) Shares are held through Daniel Frutig, his close relatives
(Eva Frutig, Anna Frutig) and an associated company (EvolutionF AG).
15 (#_ftnref15) Shares are jointly held by Norma Corio and her close
relative (Lawrence Corio).
16 (#_ftnref16) Shares are held through an associated company (K+Co
Consulting GmbH).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FEEBJBBTMTABBPA
Copyright 2019 Regulatory News Service, all rights reserved